CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4734)
Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic ...Show all
Company (Alive / Active)
Phone: 318-349-3851
2403 Sidney Street
Suite 261
Pittsburgh, 15203
Pennsylvania, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Cognition Therapeutics | $73.3M | Nov 28, 2018 |
| Indel Therapeutics | $1.4M | Apr 28, 2011 |
| Ensoltek | $0M | Feb 6, 2019 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Inhibitors of cognitive decline | Oct 16, 2015 | Nov 14, 2017 | Patent |
| Isoindoline compositions and methods for treating neurodegenerative disease | Jan 30, 2015 | Oct 24, 2017 | Patent |
| Isolated compounds from turmeric oil and methods of use | Feb 01, 2012 | Nov 22, 2016 | Patent |
| Inhibitors of cognitive decline | Jun 02, 2014 | Jun 14, 2016 | Patent |
| Inhibitors of cognitive decline | Aug 02, 2010 | Nov 24, 2015 | Patent |
